Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
PHASE3
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05
PHASE3
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)
PHASE3
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age
PHASE3
This Phase 3 study is a randomized, observer-blind immunogenicity and safet...